Nanomedicine as a promising therapeutic approach for COVID-19
The COVID-19 pandemic caused by the newly emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) puts the world in an unprecedented crisis, leaving behind huge human losses and deep socioeconomic damages. Due to the lack of specific treatment against SARS-CoV-2, effective vaccines and antiviral agents are urgently needed to properly restrain the COVID-19 pandemic. Repositioned drugs such as remdesivir have revealed a promising clinical efficacy against COVID-19. Interestingly, nanomedicine as a promising therapeutic approach could effectively help win the battle between coronaviruses (CoVs) and host cells. This review discusses the potential therapeutic approaches, in addition to the contribution of nanomedicine against CoVs in the fields of vaccination, diagnosis and therapy.
ISSN (online): 1748-6963
• chloroquine • coronavirus • COVID-19 • nanomedicine • remdesivir • SARS-CoV-2
Medicine and Health Sciences | Virus Diseases
Abd Ellah, Noura H ,; F Gad, Sheryhan; Muhammad, Khalid; E Batiha, Gaber; and Hetta, Helal F, "Nanomedicine as a promising therapeutic approach for COVID-19" (2020). Books and Book Chapters. 6.